What are the risk factors for bleeding with NOAC, VKA, and antiplatelet therapy?
Risk Factors for Bleeding With NOAC, VKA, and Antiplatelet Therapy include pre-existing comorbidities, current antithrombotic regimen and adherence, concomitant medication, and lifestyle choices. Additionally, good control of blood pressure is essential to decrease the risk of bleeding on antithrombotic therapy. Adherence to current guidelines on the management of hypertension should be followed.